Vitamin D Deficiency, Impaired Lung Function and Total and Respiratory Mortality in a Cohort of Older Men: Cross-sectional and Prospective Findings from The British Regional Heart Study

Overview

Journal BMJ Open

Specialty General Medicine

Date 2021 Dec 22

PMID 34933860

Citations 1

Authors

S Goya Wannamethee

Paul Welsh

Olia Papacosta

Lucy Lennon

Peter Whincup

Affiliations

Soon will be listed here.

Abstract

Objectives: Vitamin D deficiency is associated with chronic obstructive pulmonary disease (COPD). We examined the cross-sectional association between 25-hydroxyvitamin D (25(OH)D) and lung function impairment and assessed whether vitamin D deficiency is related to long-term mortality in those with impaired lung function.

Design: Prospective study SETTING: General practices in the UK.

Participants: 3575 men aged 60-79 years with no prevalent heart failure.

Outcome Measures: Airway obstruction and mortality. The Global Initiative on Obstructive Lung diseases (GOLD) spirometry criteria was used to define airway obstruction.

Results: During the follow-up period of 20 years, there were 2327 deaths (114 COPD deaths). Vitamin D deficiency was defined as serum 25(OH)D levels<10 ng/mL; insufficiency as 25(OH)D 10-19 ng/mL; sufficient as 25(OH)D>20 ng/mL. In cross-sectional analysis, vitamin D deficiency was more prevalent in those with moderate COPD (FEV/FVC <70% and FEV 50 to <80%; FEV, forced expiratory volume in 1 s and FVC, forced vital capacity) and severe COPD (FEV/FVC <70% and FEV <50%) but not in those with mild COPD (FEV/FVC <70% and FEV80%) or restrictive lung disease (FEV/FVC 70% and FVC <80%) compared with men with normal lung function . Vitamin D deficiency was associated with increased risk of total and respiratory mortality in both men with COPD and men with restrictive lung disease after adjustment for confounders and inflammation. The adjusted HRs (95% CI) for total mortality comparing levels of 25(OH)D<10 ng/mL to 25(OH)D>=20 ng/mL were 1.39 (1.10 to 1.75), 1.52 (1.17 to 1.98), 1.58 (1.17 to 2.14) and 1.39 (0.83 to 2.33) for those with no lung impairment, restrictive lung function, mild/moderate COPD and severe COPD, respectively.

Conclusion: Men with COPD were more likely to be vitamin D deficient than those with normal lung function. Vitamin D deficiency is associated with increased all-cause mortality in older men with no lung impairment as well as in those with restrictive or obstructive lung impairment.

Citing Articles

Organic Synthesis of New Secosteroids from Fucosterol, Its Intestinal Absorption by Caco-2 Cells, and Simulation of the Biological Activities of Vitamin D.

Komba S, Hase M, Kotake-Nara E Mar Drugs. 2023; 21(10).

PMID: 37888475 PMC: 10608315. DOI: 10.3390/md21100540.

References

Sethi S . Infection as a comorbidity of COPD. Eur Respir J. 2010; 35(6):1209-15. DOI: 10.1183/09031936.00081409. View

Khaw K, Luben R, Wareham N . Serum 25-hydroxyvitamin D, mortality, and incident cardiovascular disease, respiratory disease, cancers, and fractures: a 13-y prospective population study. Am J Clin Nutr. 2014; 100(5):1361-70. PMC: 4196486. DOI: 10.3945/ajcn.114.086413. View

Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong J . Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ. 2014; 348:g1903. PMC: 3972416. DOI: 10.1136/bmj.g1903. View

Choi C, Seo M, Choi W, Kim K, Youn S, Lindsey T . Relationship between serum 25-hydroxyvitamin D and lung function among Korean adults in Korea National Health and Nutrition Examination Survey (KNHANES), 2008-2010. J Clin Endocrinol Metab. 2013; 98(4):1703-10. DOI: 10.1210/jc.2012-3901. View

Lee H, Liu M, Lee K, Luo Y, Wong N . Does low vitamin D amplify the association of COPD with total and cardiovascular disease mortality?. Clin Cardiol. 2014; 37(8):473-8. PMC: 6649375. DOI: 10.1002/clc.22284. View

Rosen C, Abrams S, Aloia J, Brannon P, Clinton S, Durazo-Arvizu R . IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab. 2012; 97(4):1146-52. PMC: 5393439. DOI: 10.1210/jc.2011-2218. View

Holick M . Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. DOI: 10.1056/NEJMra070553. View

Brondum-Jacobsen P, Benn M, Jensen G, Nordestgaard B . 25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol. 2012; 32(11):2794-802. DOI: 10.1161/ATVBAHA.112.248039. View

Persson L, Aanerud M, Hiemstra P, Michelsen A, Ueland T, Hardie J . Vitamin D, vitamin D binding protein, and longitudinal outcomes in COPD. PLoS One. 2015; 10(3):e0121622. PMC: 4372215. DOI: 10.1371/journal.pone.0121622. View

10.

Lennon L, Ramsay S, Papacosta O, Shaper A, Wannamethee S, Whincup P . Cohort Profile Update: The British Regional Heart Study 1978-2014: 35 years follow-up of cardiovascular disease and ageing. Int J Epidemiol. 2015; 44(3):826-826g. PMC: 4521137. DOI: 10.1093/ije/dyv141. View

11.

Wannamethee S, Welsh P, Papacosta O, Lennon L, Whincup P, Sattar N . Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circ Heart Fail. 2014; 7(5):732-9. DOI: 10.1161/CIRCHEARTFAILURE.114.001272. View

12.

Kunisaki K, Niewoehner D, Singh R, Connett J . Vitamin D status and longitudinal lung function decline in the Lung Health Study. Eur Respir J. 2010; 37(2):238-43. PMC: 3070416. DOI: 10.1183/09031936.00146509. View

13.

Martineau A, Jolliffe D, Hooper R, Greenberg L, Aloia J, Bergman P . Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017; 356:i6583. PMC: 5310969. DOI: 10.1136/bmj.i6583. View

14.

Knox S, Harris J, Calton L, Michael Wallace A . A simple automated solid-phase extraction procedure for measurement of 25-hydroxyvitamin D3 and D2 by liquid chromatography-tandem mass spectrometry. Ann Clin Biochem. 2009; 46(Pt 3):226-30. DOI: 10.1258/acb.2009.008206. View

15.

Rabe K, Watz H . Chronic obstructive pulmonary disease. Lancet. 2017; 389(10082):1931-1940. DOI: 10.1016/S0140-6736(17)31222-9. View

16.

Forouhi N, Ye Z, Rickard A, Khaw K, Luben R, Langenberg C . Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia. 2012; 55(8):2173-82. DOI: 10.1007/s00125-012-2544-y. View

17.

Mattila T, Vasankari T, Rissanen H, Knekt P, Sares-Jaske L, Jaaskelainen T . Airway obstruction, serum vitamin D and mortality in a 33-year follow-up study. Eur J Clin Nutr. 2018; 73(7):1024-1032. DOI: 10.1038/s41430-018-0299-3. View

18.

Puhan M, Siebeling L, Frei A, Zoller M, Bischoff-Ferrari H, Ter Riet G . No association of 25-hydroxyvitamin D with exacerbations in primary care patients with COPD. Chest. 2013; 145(1):37-43. DOI: 10.1378/chest.13-1296. View

19.

Wannamethee S, Shaper A, Papacosta O, Lennon L, Welsh P, Whincup P . Lung function and airway obstruction: associations with circulating markers of cardiac function and incident heart failure in older men-the British Regional Heart Study. Thorax. 2016; 71(6):526-34. PMC: 4893123. DOI: 10.1136/thoraxjnl-2014-206724. View

20.

Ross A, Manson J, Abrams S, Aloia J, Brannon P, Clinton S . The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2010; 96(1):53-8. PMC: 3046611. DOI: 10.1210/jc.2010-2704. View